BACKGROUND: In young adults with acute myeloid leukemia (AML), intensification of the anthracycline dose during induction therapy has improved the rate of complete remission but not of overall survival. We evaluated the use of cytarabine plus either standard-dose or high-dose daunorubicin as inducti...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!